Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting Delta-like ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)

This article is protected by copyright. All rights reserved.PMID:37694295 | DOI:10.1002/jcph.2346

Source: The Journal of Clinical Pharmacology - September 11, 2023 Category: Drugs & Pharmacology Authors: Di Zhou Lauren A Byers Beate Sable Marie-Anne Damiette Smit Nooshin Hashemi Sadraei Sandeep Dutta Vijay V Upreti Source Type: research